HealthEquity missed Q4 earnings but raised 2026 outlook, stock near 52-week high.

HealthEquity reported fourth-quarter earnings of $0.82 per share, missing the $0.90 consensus, and updated its fiscal 2026 guidance with EPS expected between $3.87 and $3.95, above estimates, and revenue of $1.3 billion, in line with forecasts. The stock closed at $98.64 on October 8, 2025, with a 52-week range of $74.07 to $116.65. Despite a slight dip in earnings, analysts maintain a "Moderate Buy" rating with a $119.00 target. Insiders sold about $1.02 million in shares, reducing their ownership to 1.50%, while institutional investors hold 99.55%. The company operates cloud-based health savings account platforms for U.S. consumers and employers.